Screening of AAK1 interaction proteins and its role in regulating global translation level in cells

doi:10.3969/j.issn.1674-8115.2023.07.004

Abstract

Abstract:

Objective ·To investigate noval interacting partners for adaptor-associated protein kinase 1 (AAK1) and AAK1-mediated biological functions besides clathrin-mediated endocytosis. Methods ·The labeled AAK1 vector and the blank control vector were transfected in HEK-293T cells, and the potential AAK1 interacting proteins were obtained by co-immunoprecipitation with agar-specific gel and mass spectrometry. Further verifications were performed by CoIP and fluorescence-based imaging. Recombinant proteins were purified in vitro and the direct interaction between proteins were confirmed by glutathione-S-transferase pulldown (GST Pulldown) assay. The regulation of AAK1 in the global protein synthesis was explored by puromycin incorporation assay. Results ·Mass spectrometry results showed that AAK1 was associated with a series of proteins, including fragile X mental retardation syndrome-related protein 1 (FXR1), FXR2 and fragile X mental retardation protein 1 (FMRP). Enriching with anti-FLAG agarose gels after exogenous transfecting of AAK1-3xFLAG and FMRP-MYC plasmids, the expression of FMRP-MYC was detected. The expression of FMRP could also be detected by CoIP with endogenous AAK1 antibodies. Fluorescence-based imaging showed that they were spatially colocalized in the cytoplasm. GST Pulldown assay showed that FMRP could pulldown recombinant HIS6-AAK1 protein. Puromycin incorporation assay showed that in the same amount of time, the number of newly synthesized peptides labeled with puromycin was positively correlated with AAK1 protein expression. Conclusion ·AAK1 directly interacts with FMRP in cytoplasm and could up-regulate global protein synthesis level.

Key words: adaptor-associated protein kinase 1 (AAK1), translation, mass spectroscopy, protein-protein interaction

CLC Number:

Q291

JIANG Guixian, HU Ronggui, WU Hao. Screening of AAK1 interaction proteins and its role in regulating global translation level in cells[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(7): 821-828.

Figures/Tables 4

TrendMD

References 34

1	CONNER S D, SCHMID S L. Identification of an adaptor-associated kinase, AAK1, as a regulator of clathrin-mediated endocytosis[J]. J Cell Biol, 2002, 156(5): 921-929.
2	CONNER S D, SCHRÖTER T, SCHMID S L. AAK1-mediated micro2 phosphorylation is stimulated by assembled clathrin[J]. Traffic, 2003, 4(12): 885-890.
3	AGAJANIAN M J, WALKER M P, AXTMAN A D, et al. WNT activates the AAK1 kinase to promote clathrin-mediated endocytosis of LRP6 and establish a negative feedback loop[J]. Cell Rep, 2019, 26(1): 79-93.e8.
4	SORENSEN E B, CONNER S D. AAK1 regulates Numb function at an early step in clathrin-mediated endocytosis[J]. Traffic, 2008, 9(10): 1791-1800.
5	GUPTA-ROSSI N, ORTICA S, MEAS-YEDID V, et al. The adaptor-associated kinase 1, AAK1, is a positive regulator of the Notch pathway[J]. J Biol Chem, 2011, 286(21): 18720-18730.
6	SHI B, CONNER S D, LIU J. Dysfunction of endocytic kinase AAK1 in ALS[J]. Int J Mol Sci, 2014, 15(12): 22918-22932.
7	NEVEU G, ZIV-AV A, BAROUCH-BENTOV R, et al. AP2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets[J]. J Virol, 2015, 89(8): 4387-4404.
8	BEKERMAN E, NEVEU G, SHULLA A, et al. Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects[J]. J Clin Invest, 2017, 127(4): 1338-1352.
9	WANG C, WANG J, SHUAI L, et al. The serine/threonine kinase AP2-associated kinase 1 plays an important role in rabies virus entry[J]. Viruses, 2019, 12(1): E45.
10	STEBBING J, KRISHNAN V, DE BONO S, et al. Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients[J]. EMBO Mol Med, 2020, 12(8): e12697.
11	WELLS C, COUÑAGO R M, LIMAS J C, et al. SGC-AAK1-1: a chemical probe targeting AAK1 and BMP2K[J]. ACS Med Chem Lett, 2020, 11(3): 340-345.
12	MARTINEZ-GUALDA B, SCHOLS D, DE JONGHE S. A patent review of adaptor associated kinase 1 (AAK1) inhibitors (2013-present)[J]. Expert Opin Ther Pat, 2021, 31(10): 911-936.
13	KIRKPATRICK L L, MCILWAIN K A, NELSON D L. Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2[J]. Genomics, 2001, 78(3): 169-177.
14	VERKERK A J, PIERETTI M, SUTCLIFFE J S, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome[J]. Cell, 1991, 65(5): 905-914.
15	SHAH S, MOLINARO G, LIU B, et al. FMRP control of ribosome translocation promotes chromatin modifications and alternative splicing of neuronal genes linked to autism[J]. Cell Rep, 2020, 30(13): 4459-4472.e6.
16	KORB E, HERRE M, ZUCKER-SCHARFF I, et al. Excess translation of epigenetic regulators contributes to fragile X syndrome and is alleviated by Brd4 inhibition[J]. Cell, 2017, 170(6): 1209-1223.e20.
17	PASCIUTO E, BAGNI C. SnapShot: FMRP interacting proteins[J]. Cell, 2014, 159(1): 218-218.e1.
18	DARNELL J C, VAN DRIESCHE S J, ZHANG C, et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism[J]. Cell, 2011, 146(2): 247-261.
19	RICHTER J D, BASSELL G J, KLANN E. Dysregulation and restoration of translational homeostasis in fragile X syndrome[J]. Nat Rev Neurosci, 2015, 16(10): 595-605.
20	EDENS B M, VISSERS C, SU J, et al. FMRP modulates neural differentiation through m⁶A-dependent mRNA nuclear export[J]. Cell Rep, 2019, 28(4): 845-854.e5.
21	TANG B, WANG T, WAN H, et al. Fmr1 deficiency promotes age-dependent alterations in the cortical synaptic proteome[J]. Proc Natl Acad Sci USA, 2015, 112(34): E4697-E4706.
22	SCHMIDT E K, CLAVARINO G, CEPPI M, et al. SUnSET, a nonradioactive method to monitor protein synthesis[J]. Nat Methods, 2009, 6(4): 275-277.
23	HENDERSON D M, CONNER S D. A novel AAK1 splice variant functions at multiple steps of the endocytic pathway[J]. Mol Biol Cell, 2007, 18(7): 2698-2706.
24	LIAN J, ZHU X, DU J, et al. Extracellular vesicle-transmitted miR-671-5p alleviates lung inflammation and injury by regulating the AAK1/NF-κB axis[J].Mol Ther, 2023, 31(5): 1365-1382.
25	SORRELL F J, SZKLARZ M, ABDUL AZEEZ K R, et al. Family-wide structural analysis of human numb-associated protein kinases[J]. Structure, 2016, 24(3): 401-411.
26	HARTZ R A, AHUJA V T, NARA S J, et al. Discovery, structure-activity relationships, and in vivo evaluation of novel aryl amides as brain penetrant adaptor protein 2-associated kinase 1 (AAK1) inhibitors for the treatment of neuropathic pain[J]. J Med Chem, 2021, 64(15): 11090-11128.
27	XIN X, WANG Y, ZHANG L, et al. Development and therapeutic potential of adaptor-associated kinase 1 inhibitors in human multifaceted diseases[J]. Eur J Med Chem, 2023, 248: 115102.
28	ASAMITSU S, YABUKI Y, IKENOSHITA S, et al. CGG repeat RNA G-quadruplexes interact with FMRpolyG to cause neuronal dysfunction in fragile X-related tremor/ataxia syndrome[J]. Sci Adv, 2021, 7(3): eabd9440.
29	HALE C R, SAWICKA K, MORA K, et al. FMRP regulates mRNAs encoding distinct functions in the cell body and dendrites of CA1 pyramidal neurons[J]. Elife, 2021, 10: e71892.
30	MAURIN T, LEBRIGAND K, CASTAGNOLA S, et al. HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein[J]. Nucleic Acids Res, 2018, 46(12): 6344-6355.
31	BUDDIKA K, XU J, ARIYAPALA I S, et al. I-KCKT allows dissection-free RNA profiling of adult Drosophila intestinal progenitor cells[J]. Development, 2021, 148(1): dev196568.
32	MAZROUI R, HUOT M E, TREMBLAY S, et al. Trapping of messenger RNA by fragile X mental retardation protein into cytoplasmic granules induces translation repression[J]. Hum Mol Genet, 2002, 11(24): 3007-3017.
33	MONDAY H R, KHAROD S C, YOON Y J, et al. Presynaptic FMRP and local protein synthesis support structural and functional plasticity of glutamatergic axon terminals[J]. Neuron, 2022, 110(16): 2588-2606.e6.
34	KUAI L, ONG S E, MADISON J M, et al. AAK1 identified as an inhibitor of neuregulin-1/ErbB4-dependent neurotrophic factor signaling using integrative chemical genomics and proteomics[J]. Chem Biol, 2011, 18(7): 891-906.

[1]	LUAN Jiayan, LI Peng, HAN Bangmin. Role of SUMOylation in spermatogenesis [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(7): 925-930.
[2]	FENG Yiyuan, XU Zhongyun, DING Lin, YIN Yafu, WANG Hui, CHENG Weiwei. Initiation and regulatory mechanism of C9ORF72 (G₄C₂)_n RAN translation [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(10): 1482-1489.
[3]	LI Dong-liang, LAI Yu-chen, ZHANG Wei-wei, WANG Jian, LI Chun-hong, WANG Su-ping, SHI Qiong-yun, ZHANG Xing, TAO Ye-xuan. Preliminary study on the construction of national major science and technology infrastructure for translational medicine in China [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(6): 701-706.
[4]	LI Qian, GAO Jing-ze, LI Yun, SONG Kun, SHEN Qian-cheng. Bioinformatics analysis of esophageal squamous cell carcinoma genomic chip and prediction of targeted drug [J]. , 2020, 40(2): 194-.
[5]	ZHANG Zhi-yuan. Oral and Maxillofacial Phenome Project: a new starting point for the sustainable development of stomatology [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(10): 1321-1323.
[6]	LI Tian-tian, SUI Yi, LIU Fang, TANG Yu-jie. Inhibition of the activity of methyltransferase Legionella pneumophilaby histone H3K14M mutation [J]. , 2019, 39(3): 224-.
[7]	MENG Guo-hao, HE Xin-heng, LU Shao-yong. Prediction of signalling pathway of synaptic cell adhesion molecules mediating early synapse formation based on bioinformatics [J]. , 2019, 39(12): 1366-.
[8]	DING Wen-jing1, WU Hui1, FAN Rong1, XU Min2, QIU Xiao-chun1. New advances in translational medicine research in the field of tumor [J]. , 2018, 38(9): 1133-.
[9]	WU Hui1, FAN Rong1, DING Wen-jing1, ZHANG Xin-man2, QIU Xiao-chun1. Recent research progress in the field of translational medicine [J]. , 2018, 38(6): 712-.
[10]	WU Hui1, ZHANG Xin-man2, DING Wen-jing1, QIU Xiao-chun1. Recent research progress in the field of translational medicine [J]. , 2018, 38(4): 481-.
[11]	WANG Yun-qian, CHEN Ying-xuan. Role of protein post-translational modifications of lysine in tumor glucose metabolism [J]. , 2016, 36(8): 1219-.
[12]	ZHANG Kan, LI Hui-yi, FANG Yi-fang. Translational medicine pathway: the health care promoted by modern life science discovering [J]. , 2014, 34(4): 407-.
[13]	ZHU Zheng-gang, FU Guo-hui, LIU Bing-ya, et al. Mechanisms and translational research based on molecular biomarkers of gastric cancer [J]. , 2012, 32(9): 1185-.
[14]	LI Jian-fang, ZHU Zheng-gang, LIU Bing-ya. Research progress of translational medicine based on tumor molecular biomarkers [J]. , 2012, 32(8): 1088-.
[15]	FAN Xian-qun, XU Xiao-fang. Current situation and prospects of translational medicine in ophthalmology [J]. , 2011, 31(8): 1057-.